• 14. Cash and cash equivalents
• 15. Trade accounts receivable
• 16. Inventories
• 17. Other current and non-current assets
• 18. Property, plant and equipment
• 19. Goodwill and other intangible assets
• 20. Accrued expenses
• 21. Other liabilities
• 22. Debt and capital lease obligations
• 23. Senior Notes
• 24. Mandatory Exchangeable Bonds
• 25. Trust preferred securities
• 26. Pensions and similar obligations
• 27. Noncontrolling interest
• 28. Fresenius SE & Co. KGaA shareholders’ equity
• 29. Other comprehensive income (loss)

18. Property, plant and equipment

As of December 31, the acquisition and manufacturing costs as well as accumulated depreciation of property, plant and equipment consisted of the following:

Depreciation on property, plant and equipment for the years 2012 and 2011 was €647 million and €568 million, respectively. It is allocated within cost of sales, selling, general and administrative expenses and research and development expenses, depending upon the use of the asset.

LEASING

Machinery and equipment as of December 31, 2012 and 2011 included peritoneal dialysis cycler machines which Fresenius Medical Care leases to customers with end-stage renal disease on a month-to-month basis and hemodialysis machines which Fresenius Medical Care leases to physicians under operating leases in an amount of €403 million and €349 million, respectively.

To a lesser extent, property, plant and equipment are also leased for the treatment of patients by other business segments.

For details of minimum lease payments see note 22, Debt and capital lease obligations.